Get started
Author

Cristina Marinela Oprean

Observed names: C. Oprean, Cristina Oprean, Cristina-Marinela Oprean
ORCID: 0000-0001-5000-5422
Observed ORCID: 0000-0001-5000-5422
OpenAlex ID: A5000508347
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · Véronique Diéras, Hyo S Han, et al. · The Lancet Oncology · 311
PDF
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
2014 · M. Aapro, H. Rugo, et al. · Annals of Oncology · 250
PDF
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC
2021 · Jacek Jassem, Filippo de Marinis, et al. · Journal of Thoracic Oncology · 212
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
2016 · Jérôme Fayette, Lori Wirth, et al. · Frontiers in Oncology · 102
PDF
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron
2016 · Matti Aapro, Meinolf Karthaus, et al. · Supportive Care in Cancer · 48
PDF
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 · J. Gligorov, B. Ataseven, et al. · European Journal of Cancer · 46
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
2024 · David R. Spigel, Afshin Dowlati, et al. · Journal of Clinical Oncology · 45
Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer
2019 · V.C. Diéras, H.S. Han, et al. · Annals of Oncology · 32
PDF
Perception of disease, dyadic coping, and the quality of life of oncology patients in the active treatment phase and their life partners: an approach based on the actor-partner interdependence model
2023 · Adelina Mihaela Ştefănuţ, Mona Vintilă, et al. · Frontiers in Psychology · 26
PDF
Well-Being, Depression, and Anxiety following Oncoplastic Breast Conserving Surgery versus Modified Radical Mastectomy Followed by Late Breast Reconstruction
2021 · Daciana Grujic, Cătălina Giurgi-Oncu, et al. · International Journal of Environmental Research and Public Health · 24
PDF
Randomized Phase Ii Study of Mehd7945A (Mehd) Vs Cetuximab (Cet) in >= 2Nd-Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (Rmscchn) Progressive On/After Platinum-Based Chemotherapy (Ptct)
2014 · J. Fayette, L.J. Wirth, et al. · Annals of Oncology · 21
The influence of cognitive schemas on the mixed anxiety-depressive symptoms of breast cancer patients
2020 · Ana Cristina Bredicean, Zorin Crăiniceanu, et al. · BMC Women s Health · 20
PDF
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients
2022 · Radu Vidra, Tudor Eliade Ciuleanu, et al. · International Journal of Environmental Research and Public Health · 16
PDF
Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature
2021 · Cristina Marinela Oprean, Larisa Maria Badau, et al. · Diagnostics · 13
PDF
FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC
2021 · R. Herbst, F. De Marinis, et al. · Journal of Thoracic Oncology · 11
PDF
Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer—Between Fear of Recurrence and Desire to Procreate
2023 · Cristina Marinela Oprean, Andrei Dorin Ciocoiu, et al. · Current Oncology · 9
PDF
Postmenopausal Breast Cancer in Women, Clinical and Epidemiological Factors Related to the Molecular Subtype: A Retrospective Cohort Study in a Single Institution for 13 Years. Follow-Up Data
2020 · Cristina Marinela Oprean, Serban Mircea Negru, et al. · International Journal of Environmental Research and Public Health · 8
PDF
Endurance of erythrocyte series in chemotherapy
2020 · Sorin Săftescu, Dorel Popovici, et al. · Experimental and Therapeutic Medicine · 8
PDF
Effectiveness and safety profile of ipilimumab therapy in previously treated patients with unresectable or metastatic melanoma - the Romanian Patient Access Program.
2019 · Dan Corneliu Jinga, Tudor Ciuleanu, et al. · PubMed · 8
No Evidence Of Increased Cyclophosphamide Toxicity Associated With The Antiemetic Agent NEPA, a Fixed-Dose Combination Of Netupitant and Palonosetron
2013 · Lee Schwartzberg, Cristina Oprean, et al. · Blood · 8
Determining factors of renal dysfunction during cisplatin chemotherapy
2020 · Sorin Săftescu, Dorel Popovici, et al. · Experimental and Therapeutic Medicine · 5
PDF
Patient-reported outcomes (PROs) in the randomized, phase III IMpower110 study of atezolizumab (atezo) vs chemotherapy in 1L metastatic NSCLC.
2020 · Filippo de Marinis, Giuseppe Giaccone, et al. · Journal of Clinical Oncology · 5
Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.
2018 · Ulrich Keilholz, Andrzej Kawecki, et al. · Journal of Clinical Oncology · 5
Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study
2025 · Teodora Hoinoiu, Daniel Piţ, et al. · Frontiers in Oncology · 4
Management of HER2-Positive Breast Cancer for a Young Patient with Visceral Crisis—The Adjuvant Role of Lifestyle Changes
2022 · Larisa Maria Badau, Andrei Dorin Ciocoiu, et al. · Current Oncology · 4
PDF
Works count: 42
Citation count: 1,257
H-index: 13
I10-index: 15
Year
Topic
Type